Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries

Abstract Background Understanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies. Methods Hospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and Philippines during respiratory se...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Pediatric Infectious Diseases Society Vol. 12; no. 7; pp. 394 - 405
Main Authors Biggs, Holly M, Simões, Eric A F, Abu Khader, Ilham, Thompson, Mark G, Gordon, Aubree, Hunt, Danielle R, DeGroote, Nicholas P, Porter, Rachael M, Bino, Silvia, Marar, Basima I, Gresh, Lionel, de Jesus-Cornejo, Joanne, Langley, Gayle, Thornburg, Natalie J, Peret, Teresa C T, Whitaker, Brett, Zhang, Yange, Wang, Lijuan, Patel, Mira C, McMorrow, Meredith, Campbell, William, Hasibra, Iris, Duka, Enkeleda, Al-Gazo, Mahmoud, Kubale, John, Sanchez, Felix, Lucero, Marilla G, Tallo, Veronica L, Azziz-Baumgartner, Eduardo, Simaku, Artan, Gerber, Susan I
Format Journal Article
LanguageEnglish
Published US Oxford University Press 31.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Understanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies. Methods Hospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and Philippines during respiratory seasons in 2015–2017. Medical chart review, parental interview, and post-discharge follow up were conducted. Respiratory specimens were tested using real-time RT-PCR for RSV. Infant characteristics associated with very severe illness (intensive care unit [ICU] admission or receipt of supplemental oxygen) were assessed using logistic regression to adjust for potential confounders (age, sex, study site, and preterm birth). Results Of 3634 enrolled hospitalized infants, 1129 (31%) tested positive for RSV. The median age of RSV-positive infants was 2.7 (IQR: 1.4–6.1) months and 665 (59%) were male. Very severe illness in 583 (52%) RSV-positive infants was associated with younger age (aOR 4.1, 95% CI: 2.6–6.5 for 0–2 compared to 9–11-months; P < .01), low weight-for-age z-score (aOR 1.9, 95% CI: 1.2–2.8; P < .01), ICU care after birth (aOR 1.6, 95% CI: 1.0–2.5; P = .048), and cesarean delivery (aOR 1.4, 95% CI: 1.0–1.8; P = .03). RSV subgroups A and B co-circulated at all sites with alternating predominance by year; subgroup was not associated with severity (aOR 1.0, 95% CI: 0.8–1.4). Nine (0.8%) RSV-positive infants died during admission or within ≤30 days of discharge, of which 7 (78%) were <6-months-old. Conclusions RSV was associated with nearly a third of infant acute illness hospitalizations in four middle-income countries during the respiratory season, where, in addition to young age, factors including low weight-for-age might be important predictors of severity. RSV prevention strategies targeting young infants could substantially reduce RSV-associated hospitalizations in middle-income countries.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present Address: Children’s Healthcare of Atlanta, Atlanta, GA, USA.
Present Affiliation: Doctoral Program in Global Health and Development, Laney Graduate School, Emory University, Atlanta, GA, USA.
Present Affiliation: Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
Present Affiliation: Novavax, Inc.
Present Affiliation: Pittsford Central School District, USA.
Present Affiliation: ICPSR, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
Present Affiliation: US Vaccines Medical Affairs, GSK, Philadelphia, PA, USA.
ISSN:2048-7207
2048-7193
2048-7207
DOI:10.1093/jpids/piad042